DDReg Honored at ET Health Conclave 2025 for Excellence in Life Sciences Services


Posted August 4, 2025 by ddregpharma

DDReg Pharma, a trusted global partner in life science industry offering a wide array of services including regulatory consulting and pharmacovigilance solutions, was recognized with two prestigious awards at the ET Health Conclave 2025

 
Gurgaon, July 27, 2025 — DDReg Pharma, a trusted global partner in life science industry offering a wide array of services including regulatory consulting and pharmacovigilance solutions, was recognized with two prestigious awards at the ET Health Conclave 2025, held at the Grand Hyatt, Gurgaon:

Excellency in Pharmaceutical Consulting & Compliance

Top Emerging Company in Life Sciences Services

Hosted by The Economic Times, the conclave brought together India’s top healthcare leaders, life sciences innovators, and policy drivers for a day of thought leadership, recognition, and forward-looking conversations in healthcare transformation.

A Celebration of Vision, Innovation, and Impact

The event featured key panels and fireside chats spotlighting the intersection of technology, wellness, and precision medicine. DDReg’s very own Neeraj Pant, Co-Founder & Director, was featured in a powerful panel discussion on “Genomics & Personalized Medicine: The Next Frontier,” alongside renowned experts from FMRI, Park Hospital, and Medlinks.

The session explored the shift from conventional therapies to next-gen treatments like CAR-T cell therapy, gene editing, and biologics, emphasizing India’s growing influence in global biotechnology and personalized medicine.

“This recognition is a reflection of our commitment to reshaping healthcare through regulatory innovation and strategic consulting,” said Neeraj Pant. “We are proud to be at the forefront of driving compliant, patient-centric solutions in an evolving global ecosystem.”

Leading the Change in Regulatory Science

The awards highlight DDReg’s continued leadership in simplifying complex regulatory processes, pharmacovigilance, and clinical research services. With industry’s increasing focus on harmonizing global regulatory frameworks for cell and gene therapies, DDReg is positioned as a trusted partner for biopharma companies entering emerging markets.

As personalized therapies become mainstream, DDReg’s agile regulatory expertise ensures that life sciences companies can bring advanced treatments to market safely, swiftly, and sustainably.

About DDReg Pharma:
DDReg Pharma is a global life science consulting firm, supporting pharmaceutical, biotech, and medical device companies across the product lifecycle. With deep scientific expertise and digital innovation, DDReg empowers clients to meet compliance requirements and accelerate market access worldwide.

Reference -: https://economictimes.indiatimes.com/news/company/corporate-trends/et-health-conclave-2025-celebrates-excellence-in-healthcare-with-thought-leadership-and-a-felicitation-ceremony/articleshow/123021020.cms

Visit our website - https://www.ddregpharma.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse Content Requests
Contact Email [email protected]
Issued By DDReg Pharma
Phone 3026012755
Business Address Units 444-451 , Tower B2, 4-floor Spaze-I-Tech Park, Sector 49, Sohna Road, Gurugram, Haryana 122018
Country India
Categories Health
Tags ddregpharma , regulatory services , lifescience consulting , pharma regulatory services , et health conclave 2025
Last Updated August 4, 2025